1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Amphista Therapeutics Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML AMX-883, Posaconazole - Acute Myeloid Leukaemia, High Risk Myelodysplastic Syndrome | Phase 1 | Recruiting | Amphista Therapeutics Ltd | 54 | 2026-09-16 | 2026-10-15 |
posaconazole (1)
United States (1)